 |
|
|
REFERENCES
151.
Harabin AL, Homer LD, Weathersby PK, Flynn ET:
An analysis of decrements in vital capacity as an index of pulmonary oxygen toxicity.
J Appl Physiol 63:1130, 1987.
151A.
Arieli R, Yalov A, Goldenshluger A: Modeling
pulmonary and CMS O2
toxicity and estimation of parameters for humans.
J Appl Physiol 92:248, 2002.
152.
Eckenhoff RG, Dougherty JH Jr, Messier AA, et
al: Progression and recovery of pulmonary oxygen toxicity in humans exposed to 5
ATA air. Aviat Space Environ Med 58:658, 1987.
153.
Miller JN, Camporesi EM, McLeod M, Feezor M:
Studies of early pulmonary oxygen toxicity in man. Anesthesiology 55(Suppl):A369,
1981.
154.
Thorsen E, Aanderud L, Aasen TB: Effects of a
standard hyperbaric oxygen treatment protocol on pulmonary function. Eur Respir
J 12:1442, 1998.
155.
Mathes DD: Bleomycin and hyperoxia exposure in
the operating room. Anesth Analg 81:624, 1995.
156.
Bilfinger TV, Hartman AR: Acute pulmonary failure
with neoadjuvant protocol including mitomycin C and surgical therapy. J Thorac Cardiovasc
Surg 102:935, 1991.
157.
Thompson CC, Bailey MK, Conroy JM, Bromley HR:
Postoperative pulmonary toxicity associated with mitomycin C therapy. South Med
J 85:1257, 1992.
158.
Donald KW: Oxygen poisoning in man. I. BMJ 1:667,
1947.
159.
Donald KW: Oxygen poisoning in man. II. BMJ
1:712, 1947.
160.
Hampson N, Atik D: Central nervous system oxygen
toxicity during routine hyperbaric oxygen therapy. Undersea Hyperb Med 30:147, 2003.
161.
Hampson NB, Simonson SG, Kramer CC, Piantadosi
CA: Central nervous system oxygen toxicity during hyperbaric treatment of patients
with carbon monoxide poisoning. Undersea Hyperb Med 23:215, 1996.
162.
Anderson B Jr, Shelton DL: Axial length in hyperoxic
myopia. In Bove AA, Bachrach AJ, Greenbaum LJ Jr
(eds): Underwater and Hyperbaric Physiology IX. Proceedings of the Ninth International
Symposium on Underwater and Hyperbaric Physiology. Bethesda, MD, Undersea and Hyperbaric
Medical Society, 1987, p 607.
163.
Palmquist BM, Philipson B, Barr PO: Nuclear cataract
and myopia during hyperbaric oxygen therapy. Br J Ophthalmol 68:113, 1984.
164.
Kol S, Adir Y, Gordon CR, Melamed Y: Oxy-helium
treatment of severe spinal decompression sickness after air diving. Undersea Hyperb
Med 20:147, 1993.
165.
Goldenberg I, Shupak A, Shoshani O: Oxy-helium
treatment for refractory neurological decompression sickness: A case report. Aviat
Space Environ Med 67:57, 1996.
166.
Hunter SE, Farmer JC Jr: Ear and sinus problems
in diving. In Bove AA (ed): Diving Medicine. Philadelphia,
WB Saunders, 2004, p 431.
167.
Prefaut C, Dubois F, Roussos C, et al: Influence
of immersion to the neck in water on airway closure and distribution of perfusion
in man. Respir Physiol 37:312, 1979.
168.
Simonson SG, Pritchard RJ, Moon RE, Stolp BW:
Evaluation of two chest tube drainage systems at 2 ATA and 3 ATA. Undersea Hyperb
Med 23(Suppl):124, 1996.
169.
Hummel RS III, Ornato JP, Weinberg SM, Clarke
AM: Spark-generating properties of electrode gels used during defibrillation. A
potential fire hazard. JAMA 260:3021, 1988.
170.
Martindale LG, Milligan M, Friese P: Test of
an R-2 defibrillator adaptor in a hyperbaric chamber. J Hyperbaric Med 2:15, 1987.
171.
Moon RE, Hart BB: Operational use and patient
monitoring in a multiplace hyperbaric chamber. Respir Care Clin N Am 5:21, 1999.
172.
Van Meter K: Medical field management of the
injured diver. Respir Care Clin N Am 5:137, 1999.
173.
Weaver LK, Howe S: Normobaric measurement of
arterial oxygen tension in subjects exposed to hyperbaric oxygen. Chest 102:1175,
1992.
174.
Tenney SM: A theoretical analysis of the relationship
between venous blood and mean tissue oxygen pressures. Respir Physiol 20:283, 1974.
175.
Salzano JV, Camporesi EM, Stolp BW, Moon RE:
Physiological responses to exercise at 47 and 66 ATA. J Appl Physiol 57:1055, 1984.
176.
Moon RE, Bergquist LV, Conklin B, Miller JN:
Monaghan 225 ventilator use under hyperbaric conditions. Chest 89:846, 1986.
177.
Anthonisen NR, Bradley ME, Vorosmarti J, Linaweaver
PG: Mechanics of breathing with helium-oxygen and neon-oxygen breathing mixtures
in deep saturation diving. In Lambertsen CJ (ed):
Underwater Physiology IV: Proceedings of the Fourth Symposium on Underwater Physiology.
New York, Academic Press, 1971, p 339.
178.
Lambertsen CJ, Gelfand R, Peterson R, et al:
Human tolerance to He, Ne, and N2
at respiratory gas densities equivalent
to He-O2
breathing at depths to 1200, 2000, 3000, 4000, and 5000 feet
of sea water (Predictive Studies III). Aviat Space Environ Med 48:843, 1977.
179.
Mummery HJ, Stolp BW, deL Dear G, et al: Effects
of age and exercise on physiological dead space during simulated dives at 2.8 ATA.
J Apply Physiol 94:507, 2003.
180.
Gallagher TJ, Smith RA, Bell GC: Evaluation of
mechanical ventilators in a hyperbaric environment. Aviat Space Environ Med 49:375,
1978.
181.
Saywood AM, Howard R, Goad RF, Scott C: Function
of the Oxford Ventilator at high pressure. Anaesthesia 37:740, 1982.
182.
Holcomb JR, Matos-Navarro AY, Goldmann RW: Critical
care in the hyperbaric chamber. In Davis JC, Hunt
TK (eds): Problem Wounds: The Role of Oxygen. New York, Elsevier, 1988, p 187.
183.
Weaver LK: Air breaks with the Sechrist 500A
monoplace hyperbaric ventilator. J Hyperbaric Med 3:179, 1988.
184.
Pelaia P, Volturo P, Rocco M, et al: La ventilazione
meccanica in ambiente iperbarico: Valutazioni sperimentali del Draeger Hyperlog.
Minerva Anestesiol 56:1371, 1990.
185.
Le Masson Y, Le Pechon J-C, Barratt M, Murphy
L: Ventilator for Space Station Freedom. In Schmutz
J, Wendling J (eds): Proceedings of the Joint Meeting on Diving and Hyperbaric Medicine.
Basel, Foundation for Hyperbaric Medicine, 1992, p 78.
186.
Degauque C, Lamy M, Stas M: Use of the Logic
03 for controlled ventilation in hyperbaric oxygen therapy. Acta Anaesthesiol Belg
28:251, 1977.
187.
Lewis RP, Szafranski J, Bradford RH, et al: The
use of the Penlon Nuffield 200 in a monoplace hyperbaric oxygen chamber. An evaluation
of its use and a clinical report in two patients requiring ventilation for carbon
monoxide poisoning. Anaesthesia 46:767, 1991.
188.
Spittal MJ, Hunter SJ, Jones L: The pneuPAC hyperbaric
variant HB: A ventilator suitable for use within a one-man hyperbaric chamber.
Br J Anaesth 67:488, 1991.
189.
Briggs WD: Performance of lead-acid gelled electrolyte
batteries in the deep ocean environment. Technical Note N-1526. Washington, DC,
Naval Material Command, 1978.
190.
Brown TA, Morris G: The ignition risk with mixtures
of oxygen and nitrous oxide with halothane. Br J Anaesth 38:164, 1966.
191.
Baker AB, Unsworth IP: No ignition risk with
hyperbaric enflurane. Anaesth Intensive Care 6:157, 1978.
192.
Severinghaus JW: Hyperbaric oxygenation: Anesthesia
and drug effects. Anesthesiology 26:812, 1965.
193.
Ross JAS, Manson HJ, Shearer A, Dundas CR: Some
aspects of anaesthesia in high pressure environments. In
Smith G (ed): Proceedings of the Sixth International Congress on Hyperbaric Medicine.
Aberdeen, Scotland, Aberdeen University Press, 1977, p 449.
194.
Jacobson I, Bloor K, McDowall DG, Norman JN:
Internal carotid endarterectomy at two atmospheres of pressure. Lancet 2:546, 1963.
195.
Ledingham IM, McBride TI, Jennett WB, et al:
Fatal brain damage associated with cardiomyopathy of pregnancy, with notes on caesarean
section in a hyperbaric chamber. BMJ 4:285, 1968.
196.
Carter LH, Goldsmith GA: The ordeal of Donald
Boone. Nutrition Today Autumn:2, 1970.
197.
Holt JAG: The principles of hyperbaric and anoxic
radiotherapy. Br J Radiol 48:819, 1975.
198.
Smith WDA, Mapleson WW, Siebold K, et al: Nitrous
oxide anaesthesia induced at atmospheric and hyperbaric pressures. I. Measured pharmacokinetic
and EEG data. Br J Anaesth 46:3, 1974.
199.
Russell JB, Snider MT, Richard RB, Loomis JL:
Hyperbaric nitrous oxide as a sole anesthetic agent in humans. Anesth Analg 70:289,
1990.
200.
Hornbein TF, Eger EI II, Winter PM, et al: The
minimum alveolar concentration of nitrous oxide in man. Anesth Analg 61:553, 1982.
201.
Blenkarn GD, Aquadro C, Hills BA, Saltzman HA:
Urticaria following the sequential breathing of various inert gases at a constant
ambient pressure of 7 ATA: A possible manifestation of gas-induced osmosis. Aviat
Space Environ Med 42:141, 1971.
202.
Lambertsen CJ, Idicula J: A new gas lesion syndrome
in man, induced by "isobaric gas counterdiffusion." J Appl Physiol 39:434, 1975.
203.
Acott CJ, Gorman DF: Decompression illness and
nitrous oxide anaesthesia in a sports diver. Anaesth Intensive Care 20:249, 1992.
204.
McDowell DG: Anaesthesia in a pressure chamber.
Anaesthesia 19:321, 1964.
205.
Niermeyer S, Zamudio S, Moore LG: The people.
In Hornbein TF, Schoene RB (eds): High Altitude.
An Exploration of Human Adaptation. New York, Marcel Dekker, 2001, p 43.
206.
Hackett PH: High altitude and common medical
conditions. In Hornbein TF, Schoene RB (eds): High
Altitude. An Exploration of Human Adaptation. New York, Marcel Dekker, 2001, p
839.
207.
Wagner PD, Gale GE, Moon RE, et al: Pulmonary
gas exchange in humans exercising at sea level and simulated altitude. J Appl Physiol
61:260, 1986.
208.
Gale GE, Torre-Bueno JR, Moon RE, et al: Ventilation-perfusion
inequality in normal humans during exercise at sea level and simulated altitude.
J Appl Physiol 58:978, 1985.
209.
Hornbein TF, Schoene RB: High altitude. An exploration
of human adaptation. In Lenfant C (ed): Lung Biology
in Health and Disease. New York, Marcel Dekker, 2001.
210.
West JB, Hackett PH, Maret KH, et al: Pulmonary
gas exchange on the summit of Mount Everest. J Appl Physiol 55:678, 1983.
211.
Bencowitz HZ, Wagner PD, West JB: Effect of change
in P50 on exercise tolerance at high altitude: A theoretical study. J Appl Physiol
53:1487, 1982.
212.
Crow TJ, Kelman GR: Psychological effects of
mild acute hypoxia. Br J Anaesth 45:335, 1973.
213.
Sheffield PJ, Heimbach RD: Respiratory physiology.
In DeHart RL (ed): Fundamentals of Aerospace Medicine.
Baltimore, Williams & Wilkins, 1996, p 69.
214.
Sutton JR, Reeves JT, Wagner PD, et al: Operation
Everest II: Oxygen transport during exercise at extreme simulated altitude. J Appl
Physiol 64:1309, 1988.
215.
Severinghaus JW, Mitchell RA, Richardson BW, Singer
MM: Respiratory control at high altitude suggesting active transport regulation
of CSF pH. J Appl Physiol 18:1155, 1963.
216.
Hornbein TF, Townes BD, Schoene RB, et al: The
cost to the central nervous system of climbing to extremely high altitude. N Engl
J Med 321:1714, 1989.
217.
Cavaletti G, Tredici G: Effects of exposure to
low oxygen pressure on the central nervous system. Sports Med 13:1, 1992.
218.
Hampson NB, Camporesi EM, Stolp BW, et al: Cerebral
oxygen availability by NIR spectroscopy during transient hypoxia in man. J Appl
Physiol 69:907, 1990.
219.
John AH: The effect of maternal hypoxia on the
heart rate of the foetus in utero. Br J Anaesth 37:515, 1965.
220.
Polvi HJ, Pirhonen JP, Erkkola RU: The hemodynamic
effects of maternal hypo- and hyperoxygenation in healthy term pregnancies. Obstet
Gynecol 86:795, 1995.
221.
Reshetnikova OS, Burton GJ, Milovanov AP: Effects
of hypobaric hypoxia on the fetoplacental unit: The morphometric diffusing capacity
of the villous membrane at high altitude. Am J Obstet Gynecol 171:1560, 1994.
222.
Sobrevilla LA, Cassinelli MT, Carcelen A, Malaga
JM: Human fetal and maternal oxygen tension and acid-base status during delivery
at high altitude. Am J Obstet Gynecol 111:1111, 1971.
223.
Niermeyer S: Cardiopulmonary transition in the
high altitude infant. High Alt Med Biol 4:225, 2003.
224.
Lahiri S, DeLaney RG, Brody JS, et al: Relative
role of environmental and genetic factors in respiratory adaptation to high altitude.
Nature 261:133, 1976.
225.
Niermeyer S, Andrade P, Vargas E, Moore LG: Prolonged
postnatal cardiopulmonary transition at 3700–4000 m. High Alt Med Biol 3:439,
2002.
226.
Sartori C, Allemann Y, Trueb L, et al: Augmented
vasoreactivity in adult life associated with perinatal vascular insult. Lancet 353:2205,
1999.
227.
Hackett PH, Roach RC: High-altitude illness.
N Engl J Med 345:107, 2001.
228.
Basnyat B, Murdoch DR: High-altitude illness.
Lancet 361:1967, 2003.
229.
Johnson TS, Rock PB: Acute mountain sickness.
N Engl J Med 319:841, 1988.
230.
Honigman B, Theis MK, Koziol-McLain J, et al:
Acute mountain sickness in a general tourist population at moderate altitude. Ann
Intern Med 118:587, 1993.
231.
Larson EB, Roach RC, Schoene RB, Hornbein TF:
Acute mountain sickness and acetazolamide: Clinical efficacy and effect on ventilation.
JAMA 248:328, 1982.
232.
Johnson JS, Rock PB, Fulco CS, et al: Prevention
of acute mountain sickness by dexamethasone. N Engl J Med 310:683, 1984.
233.
Gertsch JH, Seto TB, Mor J, Onopa J: Ginkgo
biloba for the prevention of severe acute mountain sickness (AMS) starting
one day before rapid ascent. High Alt Med Biol 3:29, 2002.
234.
Kenrick PA: Altitude sickness: Gingko
biloba does not prevent altitude sickness. BMJ 327:106, 2003.
235.
Hohenhaus E, Niroomand F, Goerre S, et al: Nifedipine
does not prevent acute mountain sickness. Am J Respir Crit Care Med 150:857, 1994.
236.
Bärtsch P: High altitude pulmonary edema.
Respiration 64:435, 1997.
237.
Naeije R, De Backer D, Vachiery JL, De Vuyst P:
High-altitude pulmonary edema with primary pulmonary hypertension. Chest 110:286,
1996.
238.
Rios B, Driscoll DJ, McNamara DG: High altitude
pulmonary edema with absent right pulmonary artery. Pediatrics 75:314, 1985.
239.
Bärtsch P, Maggiorini M, Ritter M, et al:
Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med 325:1284,
1991.
240.
Schoene RB, Hackett PH, Henderson WR, et al:
High altitude pulmonary edema: Characteristics of lung lavage fluid. JAMA 256:63,
1986.
241.
Schoene RB, Swenson ER, Pizzo CJ, et al: The
lung at high altitude: Bronchoalveolar lavage in acute mountain sickness and pulmonary
edema. J Appl Physiol 64:2605, 1988.
242.
Kleger GR, Bärtsch P, Vock P, et al: Evidence
against an increase in capillary permeability in subjects exposed to high altitude.
J Appl Physiol 81:1917, 1996.
243.
West JB, Mathieu-Costello O: Stress failure of
pulmonary capillaries: Role in lung and heart disease. Lancet 340:762, 1992.
244.
Cremona G, Asnaghi R, Baderna P, et al: Pulmonary
extravascular fluid accumulation in recreational climbers: A prospective study.
Lancet 359:303, 2002.
245.
Sartori C, Allemann Y, Duplain H, et al: Salmeterol
for the prevention of high-altitude pulmonary edema. N Engl J Med 346:1631, 2002.
246.
Oelz O, Maggiorini M, Ritter M, et al: Nifedipine
for high altitude pulmonary oedema. Lancet 2:1241, 1989.
247.
Hackett PH, Roach RC, Hartig GS, et al: The effect
of vasodilators on pulmonary hemodynamics in high altitude pulmonary edema: A comparison.
Int J Sports Med 13(Suppl 1):S68, 1992.
248.
Scherrer U, Vollenweider L, Delabays A, et al:
Inhaled nitric oxide for high-altitude pulmonary edema. N Engl J Med 334:624, 1996.
249.
Anand IS, Prasad BA, Chugh SS, et al: Effects
of inhaled nitric oxide and oxygen in high-altitude pulmonary edema. Circulation
98:2441, 1998.
250.
Hackett P, Rennie D: High-altitude pulmonary
edema. JAMA 287:2275, 2002.
251.
Zhao L, Mason NA, Morrell NW, et al: Sildenafil
inhibits hypoxia-induced pulmonary hypertension. Circulation 104:424, 2001.
252.
Larson EB: Positive airway pressure for high-altitude
pulmonary oedema. Lancet 1:371, 1985.
253.
Hackett PH, Yarnell PR, Hill R, et al: High-altitude
cerebral edema evaluated with magnetic resonance imaging: Clinical correlation and
pathophysiology. JAMA 280:1920, 1998.
254.
Hackett PH: High altitude cerebral edema and
acute mountain sickness. A pathophysiology update. Adv Exp Med Biol 474:23, 1999.
255.
Yarnell PR, Heit J, Hackett PH: High-altitude
cerebral edema (HACE): The Denver/Front Range experience. Semin Neurol 20:209,
2000.
256.
Basnyat B: Isolated facial and hypoglossal nerve
palsies at high altitude. High Alt Med Biol 2:301, 2001.
257.
Winslow RM, Monge CC: Hypoxia, Polycythemia,
and Chronic Mountain Sickness. Baltimore, The Johns Hopkins University Press, 1987.
258.
Rudge FW: A case of decompression sickness at
2,437 m (8,000 feet). Aviat Space Environ Med 61:1026, 1990.
259.
Kumar KV, Waligora JM, Calkins DS: Threshold
altitude resulting in decompression sickness. Aviat Space Environ Med 61:685, 1990.
260.
Vann RD, Denoble P, Emmerman MN, Corson KS: Flying
after diving and decompression sickness. Aviat Space Environ Med 64:801, 1993.
261.
Varene P, Timbal J, Jacquemin C: Effect of different
ambient pressures on airway resistance. J Appl Physiol 22:699, 1967.
262.
Borel C, Simonds D, Guy J, et al: Effect of hypobaricity
on hypoxic ventilatory response in humans. Anesthesiology 85(Suppl):A1121, 1996.
263.
Jha SK, Anand AC, Sharma V, et al: Stroke at
high altitude: Indian experience. High Alt Med Biol 3:21, 2002.
264.
Cucinell SA, Pitts CM: Thrombosis at mountain
altitudes. Aviat Space Environ Med 58:1109, 1987.
265.
Maher JT, Levine PH, Cymerman A: Human coagulation
abnormalities during acute exposure to hypobaric hypoxia. J Appl Physiol 41:702,
1976.
266.
Bendz B, Rostrup M, Sevre K, et al: Association
between acute hypobaric hypoxia and activation of coagulation in human beings. Lancet
356:1657, 2000.
267.
Grover RF, Bärtsch P: Blood. In
Hornbein TF, Schoene RB (eds): High Altitude. An Exploration of Human Adaptation.
New York, Marcel Dekker, 2001, p 493.
268.
Safar P, Tenicela R: High altitude physiology
in relation to anesthesia and inhalation therapy. Anesthesiology 25:515, 1964.
269.
Groves BM, Reeves JT, Sutton JR, et al: Operation
Everest II: Elevated high-altitude pulmonary resistance unresponsive to oxygen.
J Appl Physiol 63:521, 1987.
270.
Dickinson JG: Severe acute mountain sickness.
Postgrad Med J 55:454, 1979.
271.
Camporesi EM: Anesthesia at different environmental
pressures. In Ehrenwerth J, Eisenkraft JB (eds):
Anesthesia Equipment. St Louis, Mosby-Year Book, 1993, p 588.
272.
James MFM, White JF: Anesthetic considerations
at moderate altitude. Anesth Analg 63:1097, 1984.
273.
Cleaton-Jones P, Moyes DG, Whittaker AM: Clinical
effects of nitrous oxide and oxygen mixtures at sea-level and at 1,700 meters altitude.
Anaesthesia 34:859, 1979.
274.
James MFM, Manson EDM, Dennett JE: Nitrous oxide
analgesia and altitude. Anaesthesia 37:285, 1982.
275.
Pederson L, Benumof J: Incidence and magnitude
of hypoxaemia with ketamine in a rural African hospital. Anaesthesia 48:67, 1993.
276.
Bishop RA, Litch JA, Stanton JM: Ketamine anesthesia
at high altitude. High Alt Med Biol 1:111, 2000.
277.
Nunn JF: Anaesthesia at altitude. In
Ward MP, Milledge JS, West JB (eds): High Altitude Medicine and Physiology. London,
Chapman & Hall, 1989, p 481.
278.
Aldrete JA, Aldrete LE: Oxygen concentrations
in commercial aircraft flights. South Med J 76:12, 1983.
279.
Cotrell JJ: Altitude exposures during aircraft
flight. Flying higher. Chest 93:81, 1988.
280.
Gong H Jr, Tashkin DP, Lee EY, Simmons MS: Hypoxia-altitude
simulation test. Evaluation of patients with chronic airway obstruction. Am Rev
Respir Dis 130:980, 1984.
281.
Schwartz JS, Bencowitz HZ, Moser KM: Air travel
hypoxemia with chronic obstructive pulmonary disease. Ann Intern Med 100:473, 1984.
282.
Dillard TA, Berg BW, Rajagopal KR, et al: Hypoxemia
during air travel in patients with chronic obstructive pulmonary disease. Ann Intern
Med 111:362, 1989.
283.
Dillard TA, Beninati WA, Berg BW: Air travel
in patients with chronic obstructive pulmonary disease. Arch Intern Med 151:1793,
1991.
284.
Vohra KP, Klocke RA: Detection and correction
of hypoxemia associated with air travel. Am Rev Respir Dis 148:1215, 1993.
285.
Christensen CC, Ryg M, Refvem OK, Skjonsberg OH:
Development of severe hypoxaemia in chronic obstructive pulmonary disease patients
at 2,438 m (8,000 ft) altitude. Eur Respir J 15:635, 2000.
286.
Christensen CC, Ryg MS, Refvem OK, Skjonsberg
OH: Effect of hypobaric hypoxia on blood gases in patients with restrictive lung
disease. Eur Respir J 20:300, 2002.
287.
Aerospace Medical Association: Medical guidelines
for air travel. Aviat Space Environ Med 67:B1, 1996.
288.
Stoller JK: Oxygen and air travel. Respir Care
45:214, 2000.
289.
Jacobson BF, Munster M, Smith A, et al: The BEST
study—a prospective study to compare business class versus economy class air
travel as a cause of thrombosis. S Afr Med J 93:522, 2003.
290.
Buckey JC Jr, Gaffney FA, Lane LD, et al: Central
venous pressure in space. J Appl Physiol 81:19, 1996.
291.
Leach CS, Alfrey CP, Suki WN, et al: Regulation
of body fluid compartments during short-term spaceflight. J Appl Physiol 81:105,
1996.
292.
Reschke MF, Bloomberg JJ, Harm DL, et al: Posture,
locomotion, spatial orientation, and motion sickness as a function of space flight.
Brain Res Brain Res Rev 28:102, 1998.
293.
Buckey JC Jr, Lane LD, Levine BD, et al: Orthostatic
intolerance after spaceflight. J Appl Physiol 81:7, 1996.
294.
Nyhan D, Kim S, Dunbar S, et al: Impaired pulmonary
artery contractile responses in a rat model of microgravity. Role of nitric oxide.
J Appl Physiol 92:33, 2002.
295.
Cowell SA, Stocks JM, Evans DG, et al: The exercise
and environmental physiology of extravehicular activity. Aviat Space Environ Med
73:54, 2002.
296.
Williams DR: The biomedical challenges of space
flight. Annu Rev Med 54:245, 2003.
297.
Kirkpatrick AW, Dulchavsky SA, Boulanger BR, et
al: Extraterrestrial resuscitation of hemorrhagic shock: Fluids. J Trauma 50:162,
2001.
298.
Campbell MR: A review of surgical care in space.
J Am Coll Surg 194:802, 2002.
299.
Campbell MR, Billica RD, Johnston SL 3rd, Muller
MS: Performance of advanced trauma life support procedures in microgravity. Aviat
Space Environ Med 73:907, 2002.
300.
Kirkpatrick AW, Nicolaou S, Campbell MR, et al:
Percutaneous aspiration of fluid for management of peritonitis in space. Aviat
Space Environ Med 73:925, 2002.
301.
Kirkpatrick AW, Hamilton DR, Nicolaou S, et al:
Focused assessment with sonography for trauma in weightlessness: A feasibility
study. J Am Coll Surg 196:833, 2003.
302.
Marescaux J, Leroy J, Gagner M, et al: Transatlantic
robot-assisted telesurgery. Nature 413:379, 2001.
303.
Ilyin EA, Korolkov VI, Skidmore MG, et al: Bion
11 mission: Primate experiments. J Gravit Physiol 7:S9, 2000.
